NasdaqGS - Delayed Quote USD

Oaktree Specialty Lending Corporation (OCSL)

19.37 -0.01 (-0.05%)
At close: May 17 at 4:00 PM EDT
19.45 +0.08 (+0.41%)
After hours: May 17 at 6:37 PM EDT

Key Executives

Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Armen Panossian J.D. CEO & Chief Investment Officer -- -- 1976
Mr. Mathew M. Pendo President -- -- 1964
Mr. Aman Kumar Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending -- -- --
Mr. Raghav Khanna Managing Director & Co-Portfolio Manager -- -- 1984
Mr. Christopher McKown MD,CFO & Treasurer -- -- 1982
Mr. Matthew Stewart C.F.A., CPA MD & COO -- -- 1985
Mr. Michael Mosticchio Investor Relations -- -- --
Ms. Mary Gallegly MD,General Counsel & Secretary -- -- --
Ms. Ashley Pak Chief Compliance Officer -- -- 1978
Mr. Sandeep Kumar Khorana Managing Director of Origination -- -- 1973

Oaktree Specialty Lending Corporation

333 South Grand Avenue
28th Floor
Los Angeles, CA 90071
United States
213 830 6300 https://www.oaktreespecialtylending.com
Industry: 
Credit Services

Description

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

Corporate Governance

Oaktree Specialty Lending Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 14, 2024 at 12:00 AM UTC

Ex-Dividend Date

June 28, 2024 at 12:00 AM UTC

Dividend Date

August 1, 2024 at 12:30 PM UTC - August 5, 2024 at 12:30 PM UTC

Oaktree Specialty Lending Corporation Earnings Date

Recent Events

May 15, 2024 at 12:00 AM UTC

40-APP/A: Applications under the Investment Company Act other than those reviewed by Office of Insurance Products

April 30, 2024 at 3:00 PM UTC

Q2 2024 Earnings Call

April 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 13, 2024 at 12:00 AM UTC

40-APP: Applications under the Investment Company Act other than those reviewed by Office of Insurance Products

February 1, 2024 at 4:00 PM UTC

Q1 2024 Earnings Call

February 1, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 30, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

January 19, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

January 10, 2024 at 12:00 AM UTC

DEFA14A: Proxy Statements

Related Tickers